Neelaveni Thangavel

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Cells

Tyrosine Kinase

Walled Carbon Nanotubes

Epidermal Growth Factor Receptor

Top Venues

Pharmaceuticals (Basel, Switzerland)

Acta pharmaceutica (Zagreb, Croatia)

International journal of medicinal chemistry

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Nem Kumar Jain, Devashri Sahu, Neelaveni Thangavel, Hafiz A Makeen, Mohammed Al Bratty, Asim Najmi, Hassan Ahmad Alhazmi, Khalid A Zoghebi, Muthumanickam Alagusundaram, Hemant Kumar Jain, Chandrasekaran Balakumar
A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality. Acta pharmaceutica (Zagreb, Croatia) 74 (1) (2024)
Nem Kumar Jain, Devashri Sahu, Neelaveni Thangavel, Hafiz A Makeen, Mohammed Al Bratty, Asim Najmi, Hassan Ahmad Alhazmi, Khalid A Zoghebi, Muthumanickam Alagusundaram, Hemant Kumar Jain, Chandrasekaran Balakumar
A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality. Acta pharmaceutica (Zagreb, Croatia) 74 (1) (2024)
Asim Najmi, Neelaveni Thangavel, Anugeetha Thacheril Mohanan, Marwa Qadri, Mohammed Albratty, Safeena Eranhiyil Ashraf, Safaa Fathy Saleh, Maryam Nayeem, Syam Mohan
Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Asim Najmi, Neelaveni Thangavel, Anugeetha Thacheril Mohanan, Marwa Qadri, Mohammed Albratty, Safeena Eranhiyil Ashraf, Safaa Fathy Saleh, Maryam Nayeem, Syam Mohan
Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Asim Najmi, Neelaveni Thangavel, Anugeetha Thacheril Mohanan, Marwa Qadri, Mohammed Albratty, Safeena Eranhiyil Ashraf, Safaa Fathy Saleh, Maryam Nayeem, Syam Mohan
Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Mahmoud M Habiballah, Syam Mohan, Nabeel Kashan Syed, Hafiz A Makeen, Qazi Mohammad Sajid Jamal, Hani Alothaid, Farkad Bantun, Alaa Alhazmi, Ali Hakamy, Yahia A Kaabi, Ghalia Samlan, Mohtashim Lohani, Neelaveni Thangavel, Mohamed Ahmed Al-Kasim
Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells. Drug design, development and therapy 16 (2022)
Neelaveni Thangavel, Mohammed Al Bratty, Sadique Akhtar Javed, Waquar Ahsan, Hassan A Alhazmi
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs. International journal of medicinal chemistry 2017 (2017)